Clindamycin
$ 43,00 – $ 326,00Price range: $ 43,00 through $ 326,00
Clofranil
$ 47,00 – $ 318,00Price range: $ 47,00 through $ 318,00
Clindamycin Gel
$ 6,00 – $ 36,00Price range: $ 6,00 through $ 36,00
Clindamycin Gel is a highly effective topical antibiotic specifically formulated to target and treat acne vulgaris. The active ingredient works by inhibiting the growth of bacteria responsible for breakouts, helping to clear existing blemishes. In addition to its antibacterial properties, this gel helps reduce the redness and swelling associated with inflammatory skin conditions. Its lightweight, non-greasy formula absorbs quickly into the skin, making it suitable for daily use as part of a regular skincare routine. Regular application promotes a clearer, smoother complexion by preventing the formation of new acne lesions over time.
Active substance: Clindamycin
SKU:
Clindamycin Gel
Category: Skin Care
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Clindamycin Gel belongs to a class of topical lincosamide antibiotics designed to target dermatological bacterial infections. Specifically prescribed for the management of inflammatory acne vulgaris, this prescription medication acts locally to reduce bacterial density and suppress free fatty acid surface concentration.
Dispensed strictly in accordance with applicable federal and state regulations, topical clindamycin represents a established agent in dermatological therapy. A comprehensive evaluation of its mechanism, pharmacokinetic profile, dosing regimens, and safety considerations is provided below.
General Overview and Pharmacological Profile
| Active ingredient | Clindamycin phosphate (1%) |
| Therapeutic class | Lincosamide antibacterial agent |
| Dosage form | Topical gel |
| Route of administration | Cutaneous / Topical |
| Primary purpose | Treatment of acne vulgaris |
| Prescription status | Prescription only (Rx) |
What it’s used for
Clindamycin Gel is indicated for the topical treatment of acne vulgaris in pediatric patients 12 years of age and older as well as adult patients. Acne vulgaris is a multifactorial inflammatory disease of the pilosebaceous unit, characterized by follicular hyperkeratinization, microbial colonization, and localized inflammatory responses. Clinical application of clindamycin gel focuses on reducing both inflammatory lesions, such as papules and pustules, and non-inflammatory comedones when used as part of a structured dermatological regimen. While primary approval covers acne vulgaris, clinical usage outside approved labeling must be evaluated by a licensed prescriber based on specific diagnostic requirements. The medication is intended solely for dermatological administration and is not designated for ophthalmic, oral, or intravaginal application.
How the drug works
The active component, clindamycin phosphate, is a water-soluble ester derived from the parent antibiotic lincomycin. Upon topical application, cellular phosphatases present within the cutaneous environment hydrolyze clindamycin phosphate into its microbiologically active form, clindamycin. Clindamycin exerts its antibacterial effect by reversibly binding to the 50S ribosomal subunit of susceptible microorganisms, specifically targeting Cutibacterium acnes (formerly classified as Propionibacterium acnes). This action inhibits bacterial protein synthesis by interfering with peptide chain initiation. Concurrently, suppression of bacterial proliferation leads to a measurable decrease in surface free fatty acids from approximately 14% to 2%, reducing the local biochemical irritation that contributes to follicular inflammation and lesion formation.
What happens in the body
Following cutaneous application of clindamycin gel, systemic absorption is minimal but present. In vitro and in vivo studies indicate that clindamycin phosphate is converted to active clindamycin within the stratum corneum and deeper epidermal layers. Bioavailability determinations demonstrate that less than 1% to 5% of the applied dose reaches systemic circulation under standard physiological conditions. Small quantities of active drug cleared systemically are eliminated predominantly via hepatic metabolism and renal excretion, with a plasma half-life varying between individuals, generally reported between 1.5 and 3 hours. Accumulation in systemic tissue remains low during standard dosing protocols; however, transdermal penetration may increase if applied to eroded, inflamed, or extensively denuded skin surfaces.
Administration, Safety, and Usage Precautions
Dosing schedule
Administration of clindamycin gel requires precise adherence to medical directives. The standard regimen for adults and pediatric patients aged 12 years and older involves applying a thin film of gel to clean, dry affected skin areas twice daily, typically in the morning and evening. Before application, the target area should be cleansed with a mild, non-comedogenic cleanser and gently patted dry. A thin layer should be smoothed over the entire area affected by acne, rather than applied spot-treatment style to individual lesions. Hands must be washed thoroughly prior to and immediately after application. Treatment duration is dictated by clinical response and prescriber evaluation, with therapeutic re-evaluation recommended if no clinical improvement is observed within 6 to 8 weeks.
Practical tips
When integrating clindamycin gel into a daily skincare protocol, application should occur after cleansing but prior to applying non-comedogenic moisturizers or cosmetics. Allow the gel to dry completely for several minutes before applying secondary topical products. Care must be taken to avoid sensitive areas, including the periorbital tissue, mucous membranes, nostrils, and broken or excoriated skin. If accidental contact with sensitive surfaces occurs, rinse thoroughly with cool water. Cosmetics may be used during treatment, provided they are non-comedogenic and non-irritating.
What you may notice early on
Initiating topical clindamycin therapy does not produce immediate lesion clearance. Patients frequently observe mild localized reactions during the initial 1 to 2 weeks of therapy, including mild skin dryness, erythema, or localized scaling. Reductions in inflammatory papules and pustules typically become noticeable after 2 to 6 weeks of consistent twice-daily application. Maximum therapeutic benefits often require several months of continuous treatment under clinical monitoring.
If you skip a dose
If a scheduled application is omitted, apply the gel as soon as remembered, unless it is nearly time for the next scheduled dose. In that event, skip the missed dose and resume the established morning or evening schedule. Do not double the applied volume or apply extra gel to compensate for a missed application, as excessive application increases the probability of skin irritation without enhancing antibacterial efficacy.
What not to combine
Topical clindamycin exhibits potential drug interactions that require clinical consideration. In vitro antagonism has been demonstrated between clindamycin and erythromycin; consequently, concurrent administration of topical or systemic erythromycin-containing products with clindamycin gel is not recommended. Additionally, clindamycin possesses neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents if sufficient systemic absorption occurs. Concomitant use of abrasive soaps, peeling agents, topical retinoids, or alcohol-containing formulations may produce cumulative dermatological irritation and should be coordinated carefully with a healthcare provider.
Adverse reactions
Topical application of clindamycin gel is generally associated with localized dermatological adverse events. The most frequently reported adverse reactions include cutaneous burning, itching, dryness, erythema, skin peeling, and oiliness. Less common dermatological events include contact dermatitis, folliculitis, and localized abdominal discomfort. Systemic absorption of topical clindamycin is low; however, systemic adverse effects reported with oral or parenteral clindamycin may theoretically occur. Most critically, pseudomembranous colitis and Clostridioides difficile-associated diarrhea (CDAD) have been reported with the use of topical clindamycin formulations. Patients experiencing severe, persistent, or watery diarrhea, abdominal cramps, or bloody stools must discontinue the medication and seek immediate medical evaluation.
Important precautions
Clindamycin Gel is contraindicated in individuals with a documented history of hypersensitivity to clindamycin, lincomycin, or any vehicle component of the gel. It is likewise contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. Regarding special populations, usage during pregnancy should be limited to clearly needed clinical circumstances determined by a physician. Caution is warranted during lactation, as it is unknown whether topically applied clindamycin is excreted in human milk in measurable quantities; nursing mothers should avoid applying gel directly to the chest region. Safety and effectiveness in pediatric patients under 12 years of age have not been established.
Storage and expiration
Clindamycin Gel should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Protect the product from freezing and excessive heat exposure. Keep the container tightly closed when not in use. Do not store in high-humidity environments such as bathrooms. Discard any product that has passed its stated expiration date printed on the tube or outer carton.
Common questions
Can clindamycin gel be used alongside benzoyl peroxide?
Combination therapy involving benzoyl peroxide and topical clindamycin is a frequent clinical approach to enhance efficacy and suppress the emergence of antibiotic-resistant strains of Cutibacterium acnes. However, concurrent application of multiple topical agents may increase localized skin dryness or irritation. Patients should consult their healthcare provider before combining topical therapies to establish an appropriate dosing routine and product sequence.
How long does a standard course of topical clindamycin treatment last?
The duration of therapy is individualized based on clinical response and prescriber judgment. Clinical evaluations usually assess efficacy after 6 to 8 weeks of continuous use. Long-term uninterrupted monotherapy with topical antibiotics is generally limited to reduce the risk of bacterial resistance development.
Is it necessary to avoid sun exposure while using clindamycin gel?
While clindamycin gel is not primarily categorized as a strong photosensitizer, inflamed skin treated with topical agents may exhibit heightened sensitivity to environmental factors. Exposure to sunlight and artificial ultraviolet radiation should be minimized. Daily application of a broad-spectrum, non-comedogenic sunscreen is recommended during dermatological treatment.
What should be done if severe gastrointestinal symptoms occur during use?
Systemic absorption of topically applied clindamycin can occasionally affect intestinal flora, potentially leading to Clostridioides difficile proliferation. If severe diarrhea, watery stools, or abdominal cramping develop at any point during or shortly after treatment, use of the gel must be discontinued immediately. Prompt evaluation by a qualified medical professional is required to rule out antibiotic-associated colitis.
This text is for informational purposes only and does not constitute individual medical advice.
In accordance with FDA requirements.
Additional information
| Dosage |
10 g ,20 g |
|---|---|
| Package |
1 tubes ,3 tubes ,6 tubes |
| Ενεργός Ουσία |
Related products
A-Ret Gel
$ 50,00 – $ 141,00Price range: $ 50,00 through $ 141,00
Active substance: Tretinoin
More Details
This product has multiple variants. The options may be chosen on the product page
Accufine
$ 69,00 – $ 323,00Price range: $ 69,00 through $ 323,00
Active substance: Isotretinoin
More Details
This product has multiple variants. The options may be chosen on the product page
Acticin
$ 50,00 – $ 103,00Price range: $ 50,00 through $ 103,00
Active substance: Permethrin
More Details
This product has multiple variants. The options may be chosen on the product page
Benoquin Cream
$ 73,00 – $ 503,00Price range: $ 73,00 through $ 503,00
Active substance: Monobenzone
More Details
This product has multiple variants. The options may be chosen on the product page
Benzac AC Gel
$ 34,00 – $ 104,00Price range: $ 34,00 through $ 104,00
Active substance: benzoyl peroxide
More Details
This product has multiple variants. The options may be chosen on the product page
Benzoyl
$ 66,00 – $ 152,00Price range: $ 66,00 through $ 152,00
Active substance: benzoyl peroxide
More Details
This product has multiple variants. The options may be chosen on the product page
Betnovate
$ 40,00 – $ 55,00Price range: $ 40,00 through $ 55,00
Active substance: betamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Dapsone
$ 80,00 – $ 180,00Price range: $ 80,00 through $ 180,00
Active substance: dapsone
More Details
This product has multiple variants. The options may be chosen on the product page
